Approval · Notice of Compliance 26061 · 2021

TRYPTAN: Notice of Compliance 26061

Issued June 11, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 26061
Date: June 11, 2021
Company: Bausch Health, Canada Inc.Laval, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Labelling Only
Reason: Update to the product monograph. change in product ownership

Products in this notice

Brand	DIN	Status today
TRYPTAN	00718149	Marketed
TRYPTAN	02239326	Marketed
TRYPTAN	02239327	Marketed
TRYPTAN	00654531	Marketed
TRYPTAN	02029456	Marketed

Medicinal ingredients

L-TRYPTOPHAN 500 MG per CAP
L-TRYPTOPHAN 250 MG per TAB
L-TRYPTOPHAN 750 MG per TAB
L-TRYPTOPHAN 1,000 MG per TAB
L-TRYPTOPHAN 500 MG per TAB